8-K - BridgeBio Pharma, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events On October 27, 2025, BridgeBio Pharma, Inc. issued a press release titled “BridgeBio Reports Positive Phase 3 Results for Small Molecule BBP-418

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release titled, “BridgeBio Reports Positive Phase 3 Results for Small Molecule B

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EXHIBIT 99.1